CRC has an immunosuppressive TME which helps prevent the development of a powerful reaction to ICB therapies. You can find Therefore an urgent should recognize the strategies reprogram this suppressive TME to be able to greatly enhance immunotherapy efficacy. In The existing study, we employed CRISPR KO screens to find out genes that sensitize CRC